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Abstract:  Tissue engineering aims to address the critical lack of immunocompatible 
tissues and organs available for grafting and transplantation.  Scaffolds are three 
dimensional, porous structures that provide shape and attachment sites for cells during 
tissue growth and are a critical component of tissue engineering.  Naturally derived 
scaffolds have seen significantly greater clinical usage than synthetic scaffolds and have 
marked advantages, including naturally present growth factors and ideal morphology.  In 
addition, scaffolds derived from xenogeneic tissues are advantageous because human 
tissues are difficult and costly to obtain.  However, careful decellularization is required to 
prevent immune rejection.  Porcine adipose tissue (PAT) is inexpensive and readily 
obtained.  This study’s objective was to develop a general tissue scaffold from PAT while 
maintaining the structure of its extracellular matrix (ECM).  Maintaining PAT’s ECM 
intact is expected to improve nutrient distribution and cell ingrowth.  Two 
decellularization methods were attempted:  methanol-chloroform submersion, and freeze-
thawing.  Methanol-chloroform submersion destroyed the tissue and was discontinued; 
freeze-thawing was successful and pursued:  the number of freeze-thaw steps (1 – 7), the 
tissue surface area and thickness, and the trypsin incubation time (1 – 3 hours) were 
evaluated and optimized.  Moreover, following an initial cell seeding study during which 
cell attachment and ingrowth did not occur, a lipid removal strategy using sonication (20 
– 60 minutes with water, trypsin, or SDS) and immersion in xylene (20 seconds to 20 
minutes) was also devised to remove all lipids and thereby create a hydrophilic 
environment conducive to cell seeding.  Processed scaffold mechanical strength and 
morphology were examined using histology slides and SEM digital micrographs. An 
additional cell seeding study using CFDA-SE stained cells was conducted.  An average 
ultimate tensile strength of 87.4 kPa, an average break strain of 53.9 kPa, an average 
elastic modulus of 324 kPa, 30% relaxation per ramp, and intact morphology, including 
tubular vascular channels were found. Cells examined in micrographs of seeded tissue 
demonstrated successful cell ingrowth and uniform distribution at 8 days.  Overall, an 
optimized decellularization process and a lipid removal processes were developed that 
retained natural tissue morphology. Moreover, obtained scaffolds compared favorably 
with small intestine submucosa (SIS), a clinically available scaffold. 
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CHAPTER I 
 
 
INTRODUCTION 
 
1.1 NEED FOR TISSUE ENGINEERING 
Organ transplantation and tissue grafting are both prevalent medical procedures.  However, 
they face traditionally insurmountable drawbacks.  First, organs are not perfectly matched to 
patients and immunosuppressant therapies are required to prevent transplant rejection [1].  Second, 
disease transmission is a significant risk [2].  Third, organ transplant waiting lists are extensive.  To 
illustrate, in 2012 there were approximately 58 thousand patients on the kidney transplant wait list.  
However, only about 18 thousand transplants were performed that year.  In addition to this three-
fold disparity between transplants and wait-listed patients, between 2011 and 2012 the number of 
candidates awaiting a transplant increased by 3% while the number of transplants performed 
decreased by 1.7% [3].  This situation is untenable and an alternative is desperately needed.   
Concerning tissue grafts, they are widely used for repair and reconstruction.  Blood vessels 
are excised and implanted during bypass surgeries, nerves are excised for motor neuron 
reconstruction and skin is excised for facial reconstruction and burn treatment.  These autografts, 
tissue grafts coming from other parts of the patient’s body, represent the “gold standard” or most 
desired material because 1) the risk of rejection is eliminated and 2) the tissue is immediately 
available without any transport logistics or wait-lists for genetically similar tissue to become 
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available.  However, autografts require a secondary operating site, increasing the risk of infection 
by placing additional load on the patient’s immune system and forcing the body to heal additional 
damage.  In addition, donor site morbidity, comprised of a variety of complications arising from 
removal of tissue, is another issue with the use of autografts [4-6].  Allografts represent the main 
alternative to autografts.  Tissue transplanted within the same species between different individuals, 
allografts face the same challenges as donor organs; a lack of supply, a risk of rejection, and the 
possibility for disease transmission from the donor. 
Tissue engineering seeks to replace grafts and donor organs alike using in vitro engineered 
tissues.  By engineering tissues, patients’ own cellular material can be used, significantly reducing 
or eliminating the risk of rejection while substantially increasing the availability of transplants and 
grafts.  In addition, obtaining cells is much less invasive than excising tissue and only a relatively 
small number of cells are required.   
A typical tissue engineering cycle is shown in Figure 1.1.  First, cells are obtained from the 
patient. A variety of stem cell and progenitor cell sources are possible.  Second, cells are cultured 
with growth medium until a sufficient number of cells is present.  Third, cells are seeded onto a 
scaffold.  Fourth, the seeded scaffold is placed in a bioreactor which supplies a continuous stream 
of nutrients (typically growth medium) while carrying away cell waste as the cells spread through 
and establish themselves in the scaffold.  A bioreactor may be as simple as a tissue culture dish 
with regularly changed growth medium or as complex as a system that pumps media through the 
scaffold, inducing a desired stress on the scaffold to assist cell growth.  Fifth, the seeded scaffold 
is implanted into the patient.  It is worth noting that many scaffolds are implanted directly, 
bypassing the cycle shown in Figure 1.1.  Instead of in vitro cell seeding and cell growth in a 
bioreactor, the in vivo environment of the body supplies cells and nutrients to the graft.  This 
approach eliminates seeding and growth time required before implantation.  However, direct 
implantation is impossible when immediate tissue functionality is required.    
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Figure 1.1:  A typical tissue engineering cycle 
1.2 HYPOTHESIS AND OBJECTIVES 
Naturally derived matrixes from various tissues such as small intestine, bladder, and skin have 
been used to support and guide the in-growth of cells and have shown promise in clinical 
applications [7].  To avoid an immune reaction due to mismatch, cells and DNA components are 
carefully removed without altering the source tissue’s extracellular matrix (ECM) distribution.  
However, these tissue matrixes are limited by source and large-scale preparations.  This is attributed 
to the heterogeneity in biophysical properties such as permeability, thickness, and matrix 
composition which affect the quality and reliability of the regenerated tissue in clinical practice.  
While a variety of specific like-to-like scaffolds (where decellularized human cadaverous tissue is 
used to replace the same tissue in a patient) have seen clinical usage [8], there is a need for general 
scaffolds which can be used to replace a variety of different tissues.  The objective of the work 
represented in this thesis is to develop a general soft tissue scaffold from a readily available, 
inexpensive source, while maintaining the tissue’s native morphology.  Maintaining the 
morphology intact is expected to improve cell viability, nutrient distribution, and cell ingrowth. 
According to the U.S. Department of Agriculture’s (USDA’s) National Agricultural Statistics 
Service (NASS) [9], in 2013, 5.42 million pigs were slaughtered in Oklahoma.  Moreover, porcine 
adipose tissue obtained from the dorsal ridge of swine, colloquially known as pig back-fat or 
fatback, is relatively inexpensive and is often discarded during processing.  A local supplier priced 
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pig back fat at $1.05 per pound (personal communication, October 17, 2014).  In addition, small 
intestine submucosa (SIS), such as scaffolds produced by Cook Biotech, is obtained from carefully 
controlled, pathogen free pigs in processes approved by The United States Food and Drug 
Administration (US FDA).  Therefore, porcine adipose tissue (PAT), specifically pig back fat, was 
chosen as the source for this study. To meet the objective, two specific aims were formulated: 
1. Create a process that decellularizes PAT while maintaining its natural morphology. 
Two decellularization methods were examined.  The first method used a 1:1 mixture of 
methanol and chloroform.  This method destroyed PAT’s ECM and was discontinued.  A 
second method, freeze-thawing, was chosen for examination based upon its use in literature 
to decellularize PAT.  Freezing and thawing the tissue repeatedly did not damage the 
tissue’s morphology. Therefore, the decellularization portion of the second method was 
optimized.  Further, the success of each optimization point was evaluated through light 
microscopy of Hematoxylin and Eosin (H&E) stained slides.  A lack of visible cell nuclei 
indicated successful decellularization.  Due to the necessity of lipid removal to match 
phobicity between the scaffold and growth medium cells are suspended in, a process was 
developed which removed the lipids from the tissue.  The concentration of DNA remaining 
in the processed scaffold was evaluated through a combination of nanodrop 
spectrophotometry and gel electrophoresis.  Negligible levels of DNA remained in 
processed PAT.  Finally, processed PAT was seeded with cells tagged with a florescent 
marker.  Cells spread throughout the matrix in three-dimensions with even distribution.  
These analyses demonstrated that the process created a viable tissue scaffold.   
2. Characterize PAT’s mechanical and physical properties. 
To understand the suitability of the scaffold, mechanical testing was conducted and 
processed PAT was examined via scanning electron microscopy (SEM).  First, a traditional 
tensile test was performed and the ultimate tensile stress and break strain for the scaffold 
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were determined.  Based upon the data obtained through tensile testing, it was confirmed 
that processed PAT is viscoelastic and multiple-step stress-relaxation (MSSR) testing was 
conducted. It was determined that processed PAT has mechanical characteristics similar to 
other soft tissue scaffolds, with predominant comparison to small intestine submucosa 
(SIS), the most successful commercial scaffold on the market.  Through SEM micrographs, 
processed PAT’s porosity and vasculature was examined.  Pores in the 150 µm range were 
examined as were intact vascular tubes. 
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CHAPTER II 
 
 
BACKGROUND:  SCAFFOLDS FOR TISSUE ENGINEERING 
 
2.1 SCAFFOLDS 
Scaffolds are a critical component of the tissue engineering process.  They are porous, 
sponge-like materials that provide the structure of the engineered tissue.  The biophysical properties 
of the scaffold, including its biocompatibility, biodegradability, mechanical properties, and 
physical structure (porosity, average pore size, pore distribution, etc.) determine its usefulness.  
Biocompatibility, typically demonstrated through in vivo animal models and cell seeding, 
demonstrates that a scaffold allows cells to grow and will not result in rejection. Cytotoxicity, when 
a scaffold is toxic to cells, can be examined through cell seeding and must be avoided.  However, 
systemic incompatibility can lead to swelling, immune rejection, or other undesirable host 
complications and requires an in vivo model for evaluation.  Biodegradability, particularly 
controlled biodegradability ensures that the scaffold breaks down as cells grow and begin producing 
extra cellular matrix (ECM) proteins.  The rate of degradation must be such that it allows seeded 
cells to establish their own ECM network while not hindering the formation of the native ECM 
network.  This concept is especially important when dealing with scaffolds made from synthetic 
materials, typically polymers that do not co-opt the ECM provided.  Naturally derived matrixes 
comprised of ECM contain the same components as native ECM, matrix turnover, the time required 
for the scaffold ECM to be replaced by the host’s ECM generated by cells after ingrowth may be 
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determined to provide more relevant insight than degradation in these cases.  Scaffold mechanical 
properties directly affect cellular biochemistry through cell mechanoreceptors [10].  Moreover, 
mechanical properties direct mesenchymal stem cell (MSC) differentiation towards different cell 
lineages (neural, myogenic, or osteogenic) [11]. 
There are two general categories of scaffolds under investigation in literature; they are 
categorized by material type.  First, scaffolds comprised of synthetic materials (polymers and 
ceramics).  Second, scaffolds comprised of ECM components (often derived from native tissues).  
Overlap between these categories does occur.  Some scaffolds are a combination of natural and 
synthetic materials.  In addition, natural polymers, ground ECM, and collagen (a naturally 
occurring ECM protein) are often processed as if they were synthetic materials.  Target tissue 
dictates materials investigated:  ceramics have material properties similar to those of bone and have 
therefore seen extensive usage as bone scaffolds.  Synthetic and natural polymers (such as gelatin, 
chitosan, and ECM proteins) are popular soft tissue scaffolds because they are not rigid and have 
characteristics comparable to soft tissues.  This thesis is focused on the development of a scaffold 
for general soft tissue applications and so the focus of this background will only cover soft tissues 
and the materials used for soft tissue engineering. 
2.1.1 Synthetic Scaffolds 
A wide range of synthetic polymers are available and are investigated as tissue scaffolds.  
Poly(lactic-co-glycolic acid) (PLGA) and polycaprolactrone (PCL) are two common synthetic 
materials under investigation.  Numerous techniques are used in the formation of scaffolds from 
synthetic materials and are separated into two categories:  additive and subtractive. 
2.1.1.1 Additive Methods 
Electrospinning:  Electrospinning uses a high voltage current to induce a thread of solvated 
polymer, extruded from the tip of a nozzle (typically extruded from a syringe using a syringe pump), 
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to pass through open air to a grounded collector plate.  Near total solvent evaporation occurs as the 
polymer travels between the nozzle tip and the collector plate which can be spun to induce a non-
random fiber orientation. Fiber sizes between 50 nm and 30 µm can be obtained using this method 
[12].  However, unevaporated solvents are a potential drawback of electrospun scaffolds as 
chloroform and other cytotoxic solvents are used [2].  See [13] for a current review on 
electrospinning. 
3D Printing:  Referred to by a variety of names, including solid freeform fabrication and rapid 
prototyping (RP), RP systems are unique in that they use computer aided manufacturing (CAM) 
and three dimensional (3D) computer aided design (CAD) models.  The CAD model can be almost 
any 3D structure imaginable.  The CAM system creates a path scheme from the CAD model that 
is executed to build the material layer by layer.  Actual printing may be achieved through a nozzle, 
by using a laser to cross-link a photoreactive polymer or hydrogel, or by fusing a powder.  The 
main limitation of RP is the achievable resolution.  For further information refer to [14]. 
Others:  Other additive methods, including layer by layer (LBL) deposition exist [15], although 
LBL deposition is typically used to create a film with desirable properties on another structure (e.g.  
an electrospun scaffold). 
2.1.1.2 Common Subtractive Methods 
Particulate leaching:  Particulate leaching is done by mixing a solid particulate, such as salt, with a 
solvated polymer.  After casting the polymer, it is submerged in one of the solid particle’s solvents 
(e.g.  water for the salt example).  The particulate then leaches out of the scaffold, leaving pores 
that correspond in size to the original particle distribution. 
Gas Foaming:  Gas at high pressure is injected into a polymer that creates a semi-connected network 
of pores of varying size [16]. 
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Freeze Drying:  Unlike particle leaching, freeze drying doesn’t require a solid particulate.  Freezing 
a solution of polymer dissolved in glacial acetic acid or benzene creates ice crystals which act as 
the particulate.  Lyophilizing (or freeze-drying) the structure extracts the liquid from the scaffold 
leaving behind a porous structure.  The pore size is controlled by the rate of freezing with a greater 
temperature gradient resulting in smaller pore size and a smaller temperature gradient resulting in 
larger ice crystals and thereby larger pores [16].  Freeze-dried scaffolds are used in the following, 
which include multiple natural polymers:  [17-19]. 
2.1.2 Naturally-derived Scaffolds 
There are several types of naturally-derived scaffolds.  Some of the same production 
techniques used for synthetic scaffolds are used with natural materials (see freeze-drying references 
above).  Decellularized tissues can be ground into powders and then formed into the desired shape 
by compression or by other means.  However, maintaining native tissue morphology during the 
decellularization process has two key advantages:  1) a natural porous structure created by voids 
previously inhabited by cells eliminate the need for additional processing to obtain a porous 
architecture and 2) intact vasculature from blood vessels and capillaries are expected to improve 
nutrient flow throughout the scaffold.  However, depending on the tissue in question, removing the 
cellular material without damaging the structure of the scaffold can represent a significant 
challenge. 
A wide variety of decellularization methods have been presented in the literature.  
Perfusion, pumping detergent through whole organ or tissue vasculature is common, especially in 
whole organs (refer to [20] for an example of perfusion).  Tissues may be immersed in detergents 
with or without agitation or other mechanical assistance, cyclically frozen and thawed, and/or 
enzymatically digested.  Numerous methods used in literature are listed by Gilbert et al. [21] and 
Crapo et al. [22] along with their mode of action and effects on the ECM.  Table 2.1 provides a 
series of decellularization methods that have been applied to adipose tissue. 
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Table 2.1:  Decellularization methods applied to PAT with references 
Method Reference 
Mechanical:  
Freeze/thaw [23-26] 
Homogenization [5] 
Freeze-drying [24, 25, 27] 
Massaging [27] 
  
Detergents:  
Sodium deoxycholate [23, 27] 
Sodium dodecyl sulfate (SDS) [27, 28] 
Triton X-100 [23, 24, 27] 
  
Solvents:  
Isopropanol [24-26] 
  
Enzymatic:  
DNase [23, 24] 
RNase [28] 
Trypsin [24-27] 
 
2.1.3 Comparison between naturally-derived and synthetic scaffolds 
Synthetic scaffolds have significant advantages compared to naturally-derived scaffolds. 
The pore size, mechanical properties, and structure of synthetic scaffolds are generally controllable 
and these properties are fixed or difficult to control for naturally-derived scaffolds.  Rapid 
prototyping or 3D printing in particular is envisioned as the ideal method that combines printing 
with 3D imaging to create scaffolds with shape and mechanical properties tailored to each patient 
[29].   However, synthetic matrixes have failed to show efficacy in clinical applications.  ECM 
contains inherent growth factors that stimulate the growth of the ECM, such as vascular endothelial 
growth factor (VEGF), transforming growth factor beta (TGF-β), basic fibroblast growth factor 
(bFGF), placenta growth factor, and insulin-like growth factor 1.  These growth factors stimulate 
ECM protein production [30], encourage angiogenesis, and regulate cell adhesion [31].  These 
growth factors are not present in synthetic matrixes. An overall comparison between naturally-
derived and synthetic scaffolds is shown in Table 2.2. 
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Table 2.2:  Comparison between naturally-derived and synthetic scaffolds 
Naturally-derived Scaffolds Synthetic Scaffolds 
Maintains growth factors and other proteins 
present in native tissues that assist cell 
seeding 
Growth factors may be chemically attached 
to the scaffold? 
Exact organ shape can be obtained by 
decellularizing whole cadaver organs 
Scaffolds can be printed from 3D CAD 
models 
Human tissues are difficult to obtain and in 
short supply; whole human organs are even 
more so. 
3D printing resolution insufficient 
Xenogenic (non-human) tissues can cause 
inflammation and rejection, decellularization 
is critical and scaffolds must be tested for 
remaining DNA content. 
Abundant supply of polymers.  Require 
careful screening for biocompatibility and 
degradation. 
Scaffolds from natural sources have been 
approved by the FDA and are used clinically 
Synthetic scaffolds are widely investigated 
by the scientific community but not used 
clinically 
Natural vasculature can be retained after 
processing. 
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2.1.4 Drawbacks of Available Naturally-Derived Scaffolds 
Two of the best known, clinically available scaffolds are SIS and acellular dermis (or skin).  
A review by Badylak [32] lists several clinically available products from porcine SIS, human and 
bovine dermis, bovine and horse pericardium, and human fascia lata.  Porcine SIS and human, 
porcine, or bovine dermis represented the majority of the scaffolds available.  Despite the clinical 
success of SIS, these scaffolds all have key disadvantages.  First, the anatomical source of the 
unprocessed material drastically affects the properties and quality of the obtained scaffold, even 
within a relatively small area (for this effect in SIS see [33]).  Second, only greatly limited 
thicknesses can be obtained.  SIS ranges in thickness from approximately 161-247 µm under 
hydrated conditions [33].  Graftjacket®, a commercially available acellular dermal product, has an 
upper limit thickness of 1.5 mm.  In contrast, dorsal porcine adipose tissue thickness can be up to 
16 mm [34]. 
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2.2 DNA Requirements 
Native tissues must be decellularized before they can be used as tissue scaffolds.  The goal of 
decellularization is to remove the cellular material, particularly DNA content, which has been 
shown to be a significant factor in immune rejection.  Crapo et al. [22] published guidelines 
regarding the mass fraction and type of DNA remaining in a scaffold after processing that is 
sufficient to limit the risk of immune rejection: 
 50 ng double stranded DNA per mg ECM dry weight or less 
 DNA fragments less than 200 base pairs 
 H&E staining reveals a nuclei-free structure. 
Zheng et al. [35] explain the consequences of poor decellularization in a 2004 study on Restore™ 
SIS, manufactured by Depuy Johnson and Johnson.  The group found visible cell nuclei in histology 
slides of the scaffold and used nested polymerase chain reaction (PCR) to demonstrate DNA was 
present in the scaffold.  Their results demonstrated that allowing the defect to heal without 
Restore™ implantation resulted in a better outcome than implanting the v scaffold.  These results 
demonstrate the necessity of ensuring DNA removal from the scaffold. DNA evaluation is routinely 
conducted through methods that are less arduous than PCR.   Spectrophotometry using a florescent 
dye such as PicoGreen or by gel-electrophoresis using dyes such as SYBR-Green or ethidium 
bromide and Nanodrop spectrophotometry are simple tests that have been used [36].  However, 
caution must be used when evaluating DNA content through nanodrop spectrophotometry:  
common organic solvents used in DNA extraction (phenol and chloroform) strongly effect the 
results of the test and skew the results.  Thermo scientific, the manufacture of the nanodrop line of 
spectrophotometers, suggests that the downstream outcome is the true indicator of DNA quality.  
In addition to solvent contamination, contamination by proteins can also occur [37].  Therefore, 
using nanodrop spectrophotometry to measure DNA content without secondary confirmation must 
be suspect. 
13 
 
2.3 MECHANICAL PROPERTIES 
2.3.1 Tissues’ Unique Mechanical Properties 
Tissue engineering mechanical property characterization is both important and challenging.  
As stated, scaffolds need to have mechanical properties that mimic those of the native tissue 
targeted for replacement (section 2.1, first paragraph).  Most tissues are anisotropic (they have 
orientation-dependent mechanical properties).  This property in soft tissues is attributed to fiber 
orientation within the ECM [38].  In addition, all tissues are viscoelastic [39].  Viscoelasticity 
describes materials that are both elastic and viscous:  they store some portion of the deformational 
energy exerted on them and dissipate the rest of it (elastic materials store all deformational energy 
and return to their initial state immediately upon relaxation, plastic materials dissipate all 
deformational energy and do not return to their original state even after force has been removed for 
an extended period of time).  Because of the energy dissipation experienced by viscoelastic 
materials, they have history-dependent characteristics (i.e. past stresses effect the current stress 
response of the material).  
The complex mechanical behavior of soft tissues is due mainly to collagen.  However, in 
the unstretched state, collagen fibrils are wavy and do not contribute to the mechanical strength of 
the tissue (the toe region).  In the initial portion of this region, elastin.  As the tissue is strained, the 
collagen fibrils straighten (analogous to a spring).  As they uncoil, they increasingly contribute to 
the tissue’s stress response until they are fully straightened resulting in the nonlinear stress 
curvature in the toe region.  Once uncoiled, the stress-strain curve becomes approximately linear 
and collagen dominates (loading region).  The result is the non-linear J-shaped stress curve or J-
curve typical of soft tissues (the loading portion of Figure 2.1) [40].  In its entirety, Figure 2.1 
demonstrates a typical stress-relaxation curve and a typical elastic response, shown for comparison.  
After the specimen experiences a constant strain-rate stress increase until it reaches a specified 
extension or strain (the J-curve), the extension (and therefore strain) is held constant and the tissue 
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is allowed to relax by some overall percent to an asymptotic minimum stress.  Conversely, the 
elastic response is characterized by constant stress at constant strain.  This illustrates the difference 
between elastic and viscoelastic tissues as the viscoelastic tissue dissipates stress and thereby loses 
energy while a perfectly elastic material has no losses and therefore maintains constant stress.   
 
Figure 2.1:  Typical elastic and viscoelastic stress response over time. Modified from [41] 
2.3.2 Characterizing Tissue Mechanical Properties 
2.3.2.1 Describing Mechanical Properties 
There is a distinct lack of consistent methods used to describe the mechanical properties of 
scaffolds based on a diverse set of characterization tools.  Hooke’s Law, which uses the Young’s 
Modulus (also modulus of elasticity) to model the linear portion of many elastic materials (e.g. 
steel) cannot properly describe viscoelastic properties except for in very limited regions of strain 
(some have described tissue properties with an initial and final modulus where the initial modulus 
roughly approximates the initial portion of the toe region and the final modulus approximates the 
semi-linear load region [42]).  However, the viscoelasticity of tissues is well understood and 
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constituent models have been developed to describe these properties.  One of the most prevalent 
models is Fung’s Quasi-linear-viscoelastic (QLV) model, first described in [43], and still present 
in recent publications [44-47].  Other models in use include an 8-chain model adapted from the 
rubber industry [47], the standard linear solid (SLS) model [48], the Helmholtz free energy density 
function model [49], models using finite element analysis [50], and multiple unique constitutive 
models created by researchers to describe their particular scaffold or tissue (see [18] for one 
example).  All constitutive models are approximations that aim to characterize the viscoelastic 
properties of the specified tissue.  However, they provide a method of approximating the total 
mechanical properties of the tissue and may give insight into an approximate mechanistic 
approximation of the tissue.  Additionally, among similarly specified models, like the QLV model 
with similarly specified elastic responses, parameters may be directly compared [51].  However, 
unless the model parameters have a mechanistic interpretation, this comparison may be of limited 
utility when comparing scaffolds for a specific use. 
2.3.2.2 Testing Methods 
Mechanical testing must be performed before any descriptors of mechanical properties can 
be obtained.  Numerous test protocols and test hardware have been used.  Rheology [52, 53], 
dynamic mechanical analysis (DMA) [54], stress-relaxation [44, 47], multi-step stress-relaxation 
[18, 46], cyclical testing [18, 45, 47], and creep testing [45] are examples of tests performed to 
characterize viscoelastic scaffold properties.  Each method has advantages and disadvantages.  For 
example, DMA can be used to measure uniaxial sinusoidal properties of tissue while rheology 
describes sinusoidal shear properties.  MSSR can demonstrate history-dependent characteristics, 
such as whether a scaffold is strain-hardening or strain-softening that the other methods cannot.  
However, the first stage is typically low strain and may not provide the same quality of data as a 
single stress-relaxation curve using the full stress range available (load cells exhibit significant 
noise at low stress).  Overall, the relevance and usefulness of a particular test depends upon the 
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properties of the scaffold, the expected application stresses, and the mechanical property or 
properties of interest. 
Although traditional elastic test methods cannot be used to completely characterize tissue 
scaffolds, they provide useful information, mainly the ultimate tensile strength and break strain of 
the scaffold.  Both uniaxial tensile and uniaxial compressive testing, the two traditional mechanical 
testing methods, are widely used to characterize tissues.  However, these methods have been 
modified and additional considerations are required for tissues and scaffolds.  For tensile testing, 
blood vessel and other tubular scaffolds are often tested by placing a short length of tubing over 
two hooks and straining the material circumferentially (Figure 2.2.a, [55]).  For other materials, 
clamping proves too difficult or impractical and the ends of a sample may be glued directly to the 
testing apparatus (Figure 2.2.b, [42]) or they may be embedded in blocks of epoxy (Figure 2.2.c, 
[56]).  Embedding must be done with care lest the resin infiltrate the tissue and change its 
mechanical properties.  Concerning, compressive testing, both confined and unconfined testing can 
be performed.  With any hydrated tissue, especially a hydrated tissue not being tested in hydrated 
conditions, it is important to consider liquid compressibility:  unconfined compression allows water 
to freely escape the scaffold while confined compression prevents liquid from escaping.  Therefore, 
direct comparisons cannot be made between data from unconfined compression testing and data 
from confined compression testing. 
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Figure 2.2:  Tensile and compressive methods used in tissue engineering.  The depicted tensile 
methods are:  a) circumferential testing, b) supergluing the ends of sample to paddles or clamps, 
and c) embedding tissue ends in epoxy resin.  Compressive methods shown depict d) unconfined 
compression and e) confined compression 
2.3.2.3 Hydration and Temperature 
 Hydration and temperature both play an important role in scaffold mechanical testing.  
Hatami-Marbini [44] conducted experiments exploring the relation between hydration and elastic 
modulus.  He attributed the hydration dependence of the elastic modulus to proteoglycan’s negative 
charge density; as the matrix is hydrated and swells, the charge density decreases.  He pointed to 
osmotic pressure change as an additional contributing factor.  Hydration is not an important factor 
for certain polymers, such as PCL.  However, temperature is still an important consideration [47].  
Overall, it is best practice to conduct all testing in a physiological solution such as phosphate 
buffered saline (PBS) at 37°C to match tonicity, hydration, and temperature of expected implant 
conditions. 
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2.3.2.4 Anisotropic Considerations 
Many tissues have anisotropic properties.  Bone, tendon, and muscle are well-known 
anisotropic materials.  In soft tissues, like tendon, the anisotropy is attributed to fiber orientation 
within the ECM of the tissue.  Many researchers mimic mechanical anisotropy using 
electrospinning with aligned fiber orientation.  Şenel Ayaz et al. [38] demonstrate one method to 
form an anisotropic scaffold via electrospinning and demonstrate that the anisotropy is due to fiber 
alignment in the scaffold.   
In addition to recognizing and creating anisotropic materials, multiple methods have been 
described to conduct multi-dimensional mechanical testing.  These include using a sphere of known 
weight to indent the surface of the material [57], using a set of hooks attached around the periphery 
of a sample with two movable arms (x and y) and a CCD camera to record strain [39], and atomic 
force microscopy (AFM) [58].  As with viscoelastic testing, the relevance of any test is related to 
the physiological stresses applied to the tissue or scaffold and the properties of interest.  For 
example, lung tissue does not experience uniaxial tensile or uniaxial compressive stress.  Instead 
the material of the lung experiences a multi-axial stress as the lungs expand and contract. 
2.3.3 Aside:  Elasticity vs. stiffness 
On a side note, when discussing mechanical properties, there is some confusion concerning 
stiffness and elasticity.  Stiffness is a property of a specific, dimensionally defined object.  Elastic 
modulus has no dimensional dependency; it is purely an intrinsic material property.  Moreover, the 
engineering definition of stiffness is the force required to cause a material to deflect by a given 
distance (k =
F
δ
, where k is the stiffness, F is the applied force, and δ is the resulting linear 
deformation).  The elastic modulus is the ratio between the stress a material experiences and the 
corresponding strain it experiences.  It is a measure related to stiffness of a sample, but it is not 
directly stiffness. To illustrate, stiffness may be calculated using the elastic modulus and 
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dimensional parameters. For axial loading, stiffness can be calculated as follows:  k =
AE
L
, where k 
is the stiffness (or spring constant) in units of, A is the cross-sectional area, E is the elastic modulus, 
and L is the length of the element (along the line of load) [59].   
20 
 
CHAPTER III 
 
 
MATERIALS AND METHODS:  OBTAINING AND ANALYZING PROCESSED PAT 
 
Porcine adipose tissue was obtained from Ralph’s Meat Packing Company, Perkins, OK.   
3.1 METHOD 1 
Samples weighing approximately 150 mg were cut by hand.  They were immersed in 100% 
ethanol for 45 minutes and placed in a 1:1 methanol and chloroform mixture for 30, 60, 90, and 
120 minutes.  Samples were rinsed with PBS and incubated in trypsin-EDTA, a proteolytic enzyme, 
(0.05% GIBCO, Life Technologies, Grand Island, NY.), at 36°C for 1 hour. They were rinsed with 
PBS again and placed in micro-centrifuge tubes. A solution of 0.5% (wt/v) SDS (> 95%, Sigma 
Aldrich, St. Louis, MO) in 0.9% saline was added and the samples were vortexed for 15 or 30 
minutes.  Then samples were homogenized, an additional 200µL SDS was added. The samples 
were centrifuged, and visually examined. 
3.2 METHOD 2 
PAT samples were sectioned by one of two methods.  First, samples were cut by hand using 
a razorblade to approximately 1cm×1cm×1-2mm or 3cm×3cm×~2mm.  Second, samples were cut 
using a meat slicer to approximately 3cm×3cm and either 1 or 2 mm thick. The final process, shown 
in Figure 3.1, works with larger samples sectioned using a meat slicer.  The decellularization 
portion of the process (all steps leading up to sonication) was optimized by selecting a relevant  
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range of values and preparing samples at intervals over the range (Table 3.1).  Outcomes were 
evaluated through routine light microscopy of histology slides stained with H&E.   
Table 3.1:  Decellularization Optimization 
Method Ethanol 
Concentration 
Freeze 
Temp  
(oC) 
Number 
of 
Cycles 
Thaw 
Time 
(min) 
Trypsination 
time at 37oC 
(hr) 
Approximate 
Sample Size 
1 30%  
-81 1 20 1.0 ~ 1x1x.2 cm 2 50%  
3 70%  
4 
50%  -81 
1 
20 1.0 ~ 1x1x.2 cm 
5 2 
6 3 
7 4 
8         1.0   
9 50%  -81 4 20 1.5 ~ 1x1x.2 cm 
10         3.5   
 
The remaining process was developed to remove lipids from the tissue. In detail, the steps are as 
follows:   
i)  The ethanol fraction (in DI water) of the freezing solution was varied between 30%, 
50%, 70%, 80%, and 90% ethanol.   
ii)  The number of freeze-thaw cycles was varied from 1 to 7.  For all of the freeze-thaw 
cycles, samples were placed in a -80°C freezer for a minimum of 1 hr and were examined upon 
removal for freezing.  In the presence of unfrozen solution, the samples were placed back into the 
freezer until freezing was successful.  This temperature was sufficient to freeze ethanol solutions 
below 80%.  Thawing was conducted for either 20 minutes or 1 hour at either ambient 
temperature or 37 °C.  Moreover, samples were either frozen from initial ambient temperature or 
from an initial temperature of 1 °C. 
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iii) Upon completion of the last freeze-thaw cycle, samples were rinsed with PBS and 
incubated in trypsin-EDTA (0.05% GIBCO) at 37oC for 1, 1.5, and 3.0 hours.   
iv) Samples were rinsed with deionized water and sonication was performed in a water 
bath sonicator (Fisher Scientific FS20 Sonic Cleaner) either for 20 minutes or 1 hour.  During 
sonication, samples were immersed in a beaker containing 0.5% (wt/v) SDS in 0.9% saline which 
was placed in the sonicator filled with approximately 47 °C tap water. 
v) Xylene immersion time from 20 seconds to 20 minutes  
Following xylene immersion, samples were either maintained in a sterile state by rinsing twice 
with 100% ethanol then storing the samples immersed in 100% ethanol in sealed petri dishes or 
they were allowed to dry overnight in a fume hood.   
 
 
Figure 3.1:  The finalized version of Method 2 
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Table 3.2:  Conditions for sonication trials. *Typical indicates the preparation method was 4 
freeze-thaw cycles, rinsing with PBS, 1.5hr incubation in trypsin-EDTA at 37°C, and rinsing with 
deionized water 
Trial 
Preparation 
Method 
Time 
(min) 
Solution 
Solution 
Temp.  
(oC) 
Comments 
1 none 20 water RT control 
2 none 60 water RT control 
3 
4 freeze-thaw 
cycles 
60 
trypsin-
EDTA 
RT 
sample trypsinized for an 
additional 30 minutes at 37 oC 
4 Typical* 60 water RT  
5 Typical 60 water 46 pure hot tap water 
6 Typical 30 water 50  
7 Typical 30 SDS RT 
sample was stored in 100% 
ethanol overnight before 
sonication 
8 Typical 30 SDS 35 sample ~ 2 cm×3cm×3 mm 
10 Typical 60 SDS 46 
 
pure hot tap water, sample 
stored in 100% ethanol before 
sonication, sample 
~1cm×2.5cm×3mm 
 
3.3 DNA CONTENT ANALYSIS 
3.3.1 DNA Extraction 
200mg and 1000mg samples of fresh PAT were cut.  The larger sample was decellularized 
and both samples were used in their entirety.  The samples were ground in a mortar using a pestle 
and liquid nitrogen.  920µL of Biase’s disruption solution [60] was added to the mortar and the 
samples were reground in liquid nitrogen to assist the disruption solution spread throughout the 
material.  The samples were transferred to 2.0mL microcentrifuge tubes and an additional 920µL 
of disruption solution was added.  The tubes were incubated at 60°C for 3 hours.  300µL of 6M 
NaCl was added, the samples were vortexed for 15 seconds, and they were centrifuged for 30 
minutes at 14,100×g (Eppendorf MiniSpin plus, Eppendorf, Hamburg Germany).  500µL of each 
supernatant was collected and transferred to new tubes.  200µL of 25:24:1 
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phenol:chloroform:isoamyl alcohol was added to the tubes, they were vortexed for 15 seconds and 
centrifuged at 14,100×g for 10 minutes.  Each supernatant was transferred to new microcentrifuge 
tubes and 500µL of cold isopropanol (1°C) was added.  The combination was vortexed for 15 
seconds and centrifuged at 14x100×g for 10 minutes.  The liquid was decanted from the tubes 
leaving only the DNA pellet.  100% ethanol was added, the samples were centrifuged at 14,100×g 
for 10 minutes, the ethanol was pipetted out and the pellets were allowed to dry for 5-10 minutes.  
The pellets were suspended in 50µL of Tris-EDTA (TE) buffer, a buffer commonly used to 
solubilize DNA and improve its stability by inhibiting DNases, and incubated overnight at 1°C.  
They were then examined; un-dissolved pellets were forced into suspension by alternately heating 
the samples with hot tap water (~46°C) and vortexing them.  
3.3.2 DNA Analysis 
DNA concentration was measured directly using nanodrop spectrophotometry (Nanodrop 
1000 Thermo Scientific, Waltham, MA). TE was used as the blank or background measurement to 
match the DNA suspension solution.  Between each measurement, the pedestal was wiped using a 
laboratory wipe. 2µL of DI H2O was pipetted onto the pedestal and it was wiped again. Each sample 
was measured four times.  The average and standard deviation for the concentration of each 
measured sample was calculated.  In addition, gel electrophoresis was used to validate DNA 
presence.  The gel electrophoresis chamber (Enduro EPL-1007-7, Phenix Research Products, 
Candler, NC) had a pole to pole distance of approximately 18cm.  Gels were 0.8% agarose in tris-
acetate-EDTA (TAE) buffer.  7µL of sample or control, 2µL of loading buffer, and 1µL of ethidium 
bromide (500µg/ml) were loaded into two wells.  TAE was used as the running buffer.  The gels 
were run at 80V for 40 minutes.  Imaging was performed using a UV gel imaging system (GelDoc-
It with attached 6100 Series Gel HR Camera, UVP, Upland, CA, capture at either 308nm or 365nm) 
and the relative gel band intensities were found using ImageJ.  The processed DNA mass fraction 
was calculated: 
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xf [
ng
mg
]  = Wp (
0.5ml Supernatant
1.84 ml DS + 0.3 ml NaCl
) (
0.007
ml
well 
0.05ml TE Buffer
) (7μl) C𝑝 
Cp [
ng
μL
] = (
Ip
Iu
) Cu [
ng
μL
] 
xf is the mass fraction in DNA per mg dry processed sample. Wp is the weight of the processed 
sample, DS is the disruption solution, Cp is the concentration of DNA extracted from the processed 
sample, Cuis the concentration of DNA extracted from the unprocessed sample.  Cu was taken to 
be the upper error for the measured average unprocessed sample DNA concentration (average plus 
standard deviation).   
3.4 HISTOLOGICAL MICROSCOPY 
For optimization, histology slides were created after each step in the decellularization 
process.  After processing (specific to each optimization step), samples were fixed in pure formalin 
(10% formaldehyde) overnight, rinsed with PBS 3 times, and stored in 100% ethanol until delivered 
to The Oklahoma Animal Disease and Diagnostics Laboratory (OADDL).  OADDL embedded 
samples in paraffin from which 4 µm thick sections were cut.  Sections were stained with 
hymatoxylin and eosin (H&E) and plated.  Prepared slides were returned to the lab.  Digital 
photomicrographs of various locations on each slide were captured by routine light microscopy 
using an inverted microscope with built-in color camera (AMG EVOS AME i2111, Life 
Technologies, Grand Island, NY).   
3.5 SCANNING ELECTRON MICROSCOPY 
A scanning electron microscope (SEM) (JEOL JSM-6360, JEOL USA Inc., Peabody, MA) was 
used to analyze the microstructure of processed PAT.  The method used was similar to previous 
publication [61], with minor modifications.  Samples were stored in a desiccator following after 
the xylene had evaporated from xylene immersed samples to maintain a low sample water content 
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until examination.  During examination, samples were cut into squares approximately 
0.5mm×0.5mm and embedded in carbon paint on the surface of an aluminum stub.  Samples were 
sputter coated for 60 seconds. Digital micrographs were obtained at an 8kV accelerating voltage. 
3.6 CELL SEEDING 
IMR-32 (ATCC® CCL-127™) neuroblastoma were purchased from American Type 
Culture Collection (ATCC®, Manassas, VA, USA) and cultured with growth medium containing 
Eagle's Minimum Essential Medium (EMEM) following the vendor’s protocol.  In brief, 
neuroblastoma were maintained in EMEM containing 10% fetal bovine serum (FBS) on tissue 
culture plastic (TCP) at standard mammalian culture conditions (37°C, 5% CO2, 95% air) in a 
humidified cell culture incubator.  Growth medium was discarded and replaced every two days.  
When confluent, cells were harvested from the TCP using trypsin and neutralized with growth 
medium, centrifuged at 125×g for 5 minutes and resuspended in growth medium.  D 
Viable cells were counted using a Trypan blue dye exclusion assay.  A 2 day cell seeding 
experiment was performed using 100,000 IMR-32 on samples approximately 1.5cm×1.5cm.  In 
addition, an 8 day cell seeding experiment was performed, also with 100,000 IMR-32.  The cells 
were pre-stained with a carboxyfluorescein diacetate-succinimidyl ester (CFDA-SE) green stain 
(Sigma Aldrich, St.  Louis, MO) before seeding.  CFDA-SE is inactive until it passively diffuses 
across the cellular membrane into the cytoplasm where its acetate groups are cleaved by esterases.  
After cleaving it becomes highly florescent and reacts with intracellular amines which prevent it 
from escaping the cell [62]. Cells in the scaffold were analyzed using both a Nikon Eclipse TE2000-
U inverted microscope (using an attached CCD camera and Prior Scientific Lumen 200 florescence 
illumination system) and a Leica TCS SP2 Confocal System (Leica DM E14 with an argon ion 
laser, 488 nm excitation).  A minimum of two processed PAT samples were seeded during each 
experiment. 
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A preliminary cell culture experiment was conducted using passage 5 human foreskin 
fibroblasts (HFF-1).  The cell culture experiment was performed similarly to the neuroblastoma 
experiment.  At day two, samples were fixed and processed for histology with H&E stain. 
3.7 MECHANICAL CHARACTERIZATION 
To characterize the mechanical properties of the scaffold, tensile samples were axially 
strained to break at a rate of 10mm/min.  Afterwards, the viscoelasticity of the scaffold was 
examined via multi stage stress relaxation (MSSR).  All testing was conducted at 37°C and the 
samples were submerged in PBS throughout the test period (hydrated conditions).  Samples were 
cute to 1 cm wide by 2-4 cm in length using a polymer template.   
Obtained sample widths were characterized from digital photographs of the sample under 
hydrated conditions with a rule next to it using ImageJ.  Figure 3.2.a is an example photograph 
demonstrating the rule placed in-plane with the submerged sample and a picture taken 
perpendicularly to it to reduce errors.  Multiple measures were made over the length of the sample 
and the average measure was taken as the sample width for all calculations.    
To characterize sample thickness, digital micrographs were captured using an inverted 
microscope (Nikon Eclipse TE2000-U, Nikon, Tokyo, Japan) with attached CCD camera as 
previously described [33, 63].  Briefly, a sliver, approximately 0.5-1 mm in thickness, was cut from 
the edge of tissue.  Samples were curled about themselves in a spiral and placed on a slide so that 
they were edge-on to it.  Using image analysis software (Sigma Scan Pro, Systat Software, Point 
Richmond, CA, USA), multiple measurements were taken over multiple micrographs of each 
sample for both dry and DI H2O wetted conditions (see Figure 3.2.b for an example micrograph).  
A same-magnification photomicrograph of a hemocytometer was used for the software’s spatial 
calibration. The average thickness was calculated and used as the sample thickness in all 
calculations. 
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Figure 3.2:  Width and thickness measurement examples. a) Example digital photograph used to 
determine the width of test sample and b) example photomicrograph used to find the thickness of 
a test sample (representative width lines shown in red). 
3.7.1 Uniaxial Tensile Testing 
Samples were strained to break at 10 mm/min crosshead speed using an INSTRON 5542 
(INSTRON, Canton, MA, USA) to match testing conditions used for SIS [33].  The paired Merlin 
control and acquisition software was used to conduct tests and record data.  Data was exported to 
Microsoft Excel.  Break stress and strain were determined in Microsoft Excel using the average 
width and sample thickness (calculated as described above).  The elastic modulus was calculated 
from the slope of the linear portion of the stress-strain curve. 
3.7.2 MSSR 
A set of four, 5-stage MSSR tests were conducted.  The ultimate strain limit was 
determined from uniaxial tensile data and was chosen to prevent destruction of the sample.  
Samples were subjected to a constant step tensile strain applied at the rate of 3.125%s-1 for 3.5s and 
1.6s (10% and 5% strain per ramp respectively).  Then the sample was allowed to relax for 60s.  
This was repeated up to either 50% or 25% strain.   In addition, the reduced relaxation function, 
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G(t), was calculated by setting each stage’s starting time to zero and normalizing each stage to the 
maximum stress experienced by the sample during that stage. 
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CHAPTER IV 
 
 
RESULTS:  OPTIMIZATION AND EVALUATION OF PAT 
4.1 SMALL SAMPLE PREPARATION AND OPTIMIZATION 
Initial sample preparation and optimization was conducted with samples approximately 
1cm×1cm×1-2mm.  The results below pertain to samples of this size.  Scale up will be discussed 
later in this chapter. 
4.1.1 Decellularization 
We hypothesized that lipid removal would improve decellularization. Method 1 (section 
3.1), which used methanol and chloroform was intended to remove lipids from the tissue. However, 
it destroyed the PAT sample and was discontinued.   
Freeze-thawing damages cells.  As water freezes, it crystalizes and the crystals pierce cell 
walls.  Repeating this process by thawing and then refreezing the tissue causes additional damage.  
Because of its widespread use for decellularization [6, 26, 64-66], freeze-thawing was examined.  
Method 2 (section 3.2) shows the successful process incorporating this technique.  A mixture of 
water and ethanol was used to increase water’s miscibility in the lipids present in the native tissue.  
Hence, samples were submerged in an ethanol:water mixture before freezing.  The ethanol percent 
was optimized by examining a range of ethanol mixtures (30%, 50%, and 70%, Figure 4.1 b-d and 
methods 1-3 in Appendix A).  Histology slides were prepared to examine the effect. Using an 
ethanol concentration of 50% resulted in the fewest number of cell nuclei visible.  
  
 
 
Figure 4.1:  Micrographs of PAT after H/E staining at various processing steps:  unprocessed PAT (a), the effects of varying the ethanol mixtures 
((b)  30%, (c)  50%, and (d)  70%) with a single freeze-thaw cycle and 1 hr trypsination at 37°C, the effects of an increasing number freeze-thaw 
cycles ((e)  2, (f)  3, and (g)  4) with 50% ethanol and 1 hour of trypsination at 37°C, and finally, the effect of 4 freeze-thaw cycles using a 50% 
ethanol mixture and trypsin incubation times of 1.5 hr and 3 hr ((h)  and (i) respectively).  Representative cell nuclei are circled for clarity.   
3
1
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Therefore, 50% ethanol was chosen as the optimal concentration; the number of freeze-thaw cycles 
using this concentration was examined (1-4 cycles, methods 5-7 in Appendix A).  Four freeze 
cycles resulted in the fewest visible cell nuclei.  Trypsinization, routinely used in cell culture to 
suspend cells by cleaving attachment proteins, was used to cleave cells from the ECM.  The 
incubation time was varied between 1.0, 1.5 and 3.0 hours (Figure 4.1 e-g, methods 8-10 in 
Appendix A) to obtain the maximum cell removal without damaging the ECM.  Figure 4.1.h 
(method 9 in Appendix A) demonstrates the result of the optimization and satisfactory cell removal 
without damage to the ECM.  Throughout this process, it was desirable to maintain short processing 
time.  Therefore, given equal outcomes, the method requiring the shortest time period was chosen.  
Consequently, the optimization resulting in 4 freeze-thaw cycles in 50% ethanol with 1.5 hours of 
trypsinization, and was used for the rest of the study. 
An initial cell seeding study conducted with HFF-1 resulted in a scaffold lacking cell 
nuclei.  This result led to the initial assumption that preparing the sample in a biological safety 
cabinet (BSC) did not adequately protect the sample from contamination.  Therefore samples were 
lyophilized for gas sterilization.  The result, shown in Figure 4.2, demonstrates lipids drawn out of 
the tissue leading to the conclusion that, unexpectedly, decellularization occurred without 
significant lipid removal.  No evidence of this unsuccessful lipid removal had been obtained earlier 
due to additional processing undergone by samples during histology.  Moreover, it was assumed 
that decellularization was synonymous with successful lipid removal.  This false assumption 
necessitated further processing.  Based on the hypothesis that PAT maintained a hydrophobic 
environment and thereby prevented the cells, suspended in hydrophilic media, from infiltrating and 
attaching to the decellularized PAT.  Therefore, a processes to remove lipids from the scaffold was 
created. 
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Figure 4.2:  Lipid pool around lyophilized, processed scaffolds. 
4.1.2 Lipid Removal 
The effect of increasing concentrations of ethanol and increasing freeze-thaw cycles on the 
lipid content of the tissue was examined using lyophilization as the result.  No effect was observed 
for up to 7 freeze-thaw cycles with a 90% ethanol solution.  Therefore other means of lipid removal 
were sought.   
Mechanical stimulation has often been used to extract cellular material from scaffolds [21, 
22].  Hence, sonication was examined as a possible extraction method using several sonication 
solutions.  Sonicating the scaffolds during the trypsinization step, with DI H2O, and with SDS were 
examined.  In addition, because of the low melting point of lipids, the effect of increasing the 
temperature of the sonication solution was examined.  Sonicating PAT in SDS yielded visible 
results (Figure 4.3.a).  Twenty minutes of sonication at room temperature resulted in a white 
scaffold (Figure 4.3.b). 
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Figure 4.3:  Visual sonication results.  a) Lipids visible in SDS solution after sonication. b) White 
tissue obtained after 4 freeze-thaw cycles in 50% ethanol, 1.5 hours of trypsinization, and 20 
minutes of sonication at 20°C. 
4.2 SCALE UP:  LARGE SAMPLE PREPARATION 
Larger samples were desirable due to the difficulty of obtaining large numbers of small 
samples, the need for larger samples for mechanical testing, and to demonstrate successful scale-
up to useful size.  However, outcomes with larger samples cut by hand varied widely enough that 
it was impossible to ascertain the affect processing methods had on decellularization.  To address 
this issue, a meat slicer was used to create uniform samples with a consistent thickness and to 
reduce diffusional variability between samples.  This consistency allowed us to decellularize larger 
samples approximately 3cm×3cm×1mm.  In addition to increasing uniformity, the food slicer cut 
thinner samples, improving the diffusional characteristics of the material.  Samples with uniform 
thickness demonstrated a marked improvement in lipid removal and overall outcome.   
When sonicating larger samples, heating the water in the sonicator led to greater lipid 
removal.  Therefore, hot tap water (~47°C) was used as the sonication solution to increase bath 
temperature.  To ensure the sample thawed completely before being refrozen a 1 hr thaw time at 
37°C was adopted.  However, samples were placed into the freezer directly after the thawing period.  
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Previously published articles indicate that the greater the temperature gradient experienced during 
freezing, the smaller the resulting crystals   [16, 67].  This effect decreases the damage done to the 
cells during freezing and thawing.  Therefore, the original thaw conditions (20 minutes at room 
temperature) were reinstated and a step to decrease the freezing temperature gradient was added:  
after samples thawed, they were placed in refrigeration (1°C) for 20 minutes before they were 
transferred to the freezer.  Improved lipid removal was observed using this method, as determined 
by rubbing a processed sample between the thumb and forefinger and examining the oil expelled 
from the tissue.  However, even with this additional step, lipids could be extracted from the tissue.  
Therefore, the ability of organic solvents to remove the remaining lipids from the scaffold was 
examined.  Submerging samples in 0.208M acetic acid increased the oiliness of the scaffold surface 
after drying but failed to remove the lipids.  Submerging samples in xylene for 20 seconds failed 
to remove sufficient lipids from the scaffolds.  Increasing xylene submersion time to 17 minutes 
resulted in a lack of lipids being expunged from the tissue with mechanical stimulation.  As a 
beneficial side effect, the use of xylene appears to sterilize the scaffolds (as evidenced by a 
successful 8-day cell culture following xylene immersion and storage in ethanol).  Method 2, the 
final method, which successfully decellularized PAT and removed the lipids from it, is shown in 
Figure 3.1 (method 34 in Appendix A). 
4.3 DNA REMOVAL 
A primary requirement for using natural matrixes is ensuring removal of donor DNA 
components that could otherwise induce an inflammatory response and immune-mediated tissue 
rejection.  To ensure processed PAT had a negligible amount of donor DNA, the DNA content of 
unprocessed and processed PAT was determined.  First, nanodrop spectrophotometry was 
performed to directly measure DNA concentrations (Table 4.1).  Following DNA extraction and 
suspension in TE buffer, the processed sample was milky.  This observation was unsurprising since 
the processed sample weight was significantly greater than the weight of the unprocessed sample 
 36 
 
and was comprised almost exclusively of ECM proteins.  This observation also created a potential 
problem:  nanodrop spectrophotometry results can be skewed by protein contamination.  The 
a260/a280 ratio obtained for the processed sample supported the conclusion that the processed 
sample measurement was skewed by protein contamination.  A secondary DNA quantification 
method was used to determine the concentration of the processed sample DNA.   
Table 4.1:  Nanodrop spectrophotometry results (n = 4, averages will be reported within this 
thesis as average±standard deviation; where n is the sample size). 
Sample 
Concentration 
(ng/µL) 
A260 260/280 260/230 
Unprocessed Sample 47.2±8.22 0.944±0.164 1.90±0.057 0.750±0.081 
Processed Sample 31.3±2.19* 0.626±0.044 1.75±0.055 0.208±0.015 
*Datum unreliable, refer to text for explanation. 
  
 DNA content in the processed sample was calculated by using unprocessed average DNA 
concentration plus one standard deviation as a worse case.  ImageJ was used to find the intensity 
of each band and the relative band intensity of the processed sample, 
Ip
Iu
, was calculated.  In 
combination with the average measured weight reduction caused by processing (79.1±3.98%, n = 
4) and the volumes and weights used for extraction, the DNA mass fraction of the unprocessed 
sample was calculated.  Using the relative intensity, and unprocessed mass for each sample 
extracted, the DNA mass fraction was calculated.  It was found to be 0.218 ng DNA per mg dry 
scaffold.  The total reduction in DNA was also calculated; it was found to be 99.92%. 
Crapo et al. [22] published an upper DNA mass fraction of 50 ng DNA per mg dry scaffold 
sufficient to prevent the sample from rejecting upon implantation.  Compared to the 0.218 ng/mg 
mass fraction of the processed scaffold, this content is negligible compared to the published value.  
Therefore, Method 2 successfully decellularizes PAT. 
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Figure 4.4:  Image of 0.8% agarose gel run for 40 minutes at 80V.  Lane 2 contains the 
unprocessed PAT sample.  Lane 6 contains the processed PAT sample. 
4.4 PROCESSED PAT MORPHOLOGY 
Scaffold morphology, including pore size distribution, homogeneity, and channel structure 
are expected to strongly affect both cell ingrowth and nutrient distribution during the growth phase 
prior to angiogenesis.  Naturally formed matrices have the desired architecture.  To understand 
PAT’s microarchitecture, samples were analyzed via SEM.  SEM demonstrated that PAT lacks 
sidedness (Figure 4.5.a-b), unlike SIS.  It further confirmed that PAT has a porous structure with a 
useful pore size (approximately 150 µm, Figure 4.5.c-d).  Intact vascular structures were sought 
and an extensive vascular network was found (Figure 4.5.e). Moreover, It was confirmed that 
vascular tubes were present (Figure 4.5.f).  As can be seen, cooling samples before freezing them 
does not appear to have changed the tissue microarchitecture appreciably (Figure 4.5.a,c,f were 
uncooled before freezing, Figure 4.5.b,d,e were cooled before freezing). 
  
 
Figure 4.5:  Microarchitecture of PAT after processing. Samples a, c and f did not have the temperature decrease step prior to freezing.  
Micrographs show (a-b) lack of sidedness, (c-d) porosity of processed sample, and (e-f) intact vascular structures. 
 
3
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To understand the thickness and variation of the samples cut with a meat slicer, several 
unprocessed samples were measured in multiple locations using a digital caliper.  The average 
thickness was found to be 0.825±0.216mm (n = 5).  Variation in sample thickness was attributed 
to both the gradual thawing of PAT during the cutting processes (initial cuts were frozen while the 
final few cuts were completely thawed), and to pressure and/or speed variation on the part of the 
user during cutting.  Comparing this average thickness to SIS, it was almost four fold greater than 
SIS’s 200µm thickness.  In addition to measuring the initial thickness and determining the weight 
loss of the sample during processing (see section 4.3), the thickness change before and after 
processing was examined, as were the swelling properties of processed PAT (Table 4.2).  The table 
demonstrates nearly 50% of the tissue thickness is lost during processing and PAT swells nearly 
40% in DI H2O.  Combined with the weight lost during processing, this result strongly suggests the 
majority of lipids were removed from processed PAT since water was able to infiltrate the scaffold 
and it is known that lipids are the most abundant component of adipose tissue. 
Table 4.2:  Swelling properties of processed PAT. 
Property Sample 1 Sample 2 Sample 3 Average 
Thickness—Dry (m) 590±193 248±78.9 349±77.1 396±116 
Thickness—Wet (m) 734±128 462±28.1 492±56.6 563±70.9 
 
4.5 CELL CULTURE 
The importance of growth and attachment factors to cell ingrowth and viability was 
discussed earlier (section 2.1.3).  Various steps in the decellularization process can affect these and 
other biological factors integral to the regenerative process.  For example, trypsin cleaves peptide 
bonds and could damage both the ECM and its factors with prolonged exposure.  Prolonged 
sonication can also damage the ECM.  To determine whether cell attachment and cell ingrowth 
occurs, a 2 day and an 8 day cell seeding study were conducted in 6 well plates using IMR-32.  At 
the end of the 2 day experiment, the tissue was fixed and processed.  Figure 4.6.a demonstrates a 
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cells present at two days.  However, the cells’ round shape indicated a likely lack of attachment.  
However, the 8-day cell study, which used CFDA staining to allow cell imaging through the tissue 
without histological processing, demonstrated that cells proliferated evenly throughout the scaffold 
(Figure 4.6.b).  Moreover, the non-spherical shape of the cells indicate cell attachment had occurred 
at this point.  In addition, confocal microscopy was used to image cells through a range of the tissue 
thickness.  A step size of 2.72µm was used and the constructed, full range image spans an 81.4µm 
thick portion of the scaffold.  Cells were observed in every layer of the span giving evidence that 
cells successfully infiltrated the porous structure observed earlier through SEM.  Again, cells were 
clearly not spherical and had attached to the scaffold.  Finally, additional SEM work was conducted.  
Portions of the fixed scaffold from the 8 day experiment were dried overnight in a vacuum 
desiccator before they were cut, embedded in carbon paint on aluminum stubs, and sputter coated 
for 1 minute.  Cells attached to the surface of the PAT were observed.  In some locations, numerous 
lamellapodia and filapodia were observed to be anchored to the surface of the scaffold. 
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Figure 4.6:  Cell culture results.  a) H&E slide of tissue at the end of the 2-day cell seeding 
experiment.  b) Florescent microscopy of the tissue at the end of 8 day cell seeding.  c) Full range 
confocal, florescent microscopy results of 8 day seeded tissue.  d) ECM image of cell attached 
along the ridge line shown near the center of the image. 
4.6 TENSILE PROPERTIES 
The uniaxial tensile properties of processed PAT were analyzed under hydrated conditions 
at 37C.  A representative sample’s stress-strain curve is shown in Figure 4.7.  Processed PAT 
demonstrated non-linear stress-strain behavior even at small strain ranges.  The average ultimate 
tensile strength of multiple samples was 87.4±23.1kPa (n = 3) and the average break strain was 
53.9±13.3% (n = 3).  Variation beyond that normal for biological samples was attributed to 
perforations observed in the tissue.  These perforations are likely vascular tubes (shown in Figure 
4.5.e-f) cut perpendicular to their length during sample preparation.  In addition to the presence of 
pores, even when special effort was made not to subject the scaffold to any more mechanical stress 
than absolutely necessary to complete processing these perforations still occurred in the material.  
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They were not visible to the naked eye and were therefore difficult to anticipate and cut around.  
Because of this difficulty, perforations are treated as a normal part of the tissue’s mechanical 
characteristics and samples with these perforations were not excluded from the sample set.   
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Figure 4.7:  Representative stress-strain diagram for processed PAT. Uniaxial testing was 
conducted at 10 mm/min and 37°C in PBS. 
 Concerning the behavior of processed PAT, a typical tissue J-curve is observed, as 
discussed in the background in section 2.3.1.  Clearly, non-linear behavior is observed throughout 
the loading portion of the diagram and it is difficult to isolate a single linear region with which to 
evaluate an elastic modulus.  Despite this, a semi-linear region was observed between 14% and 
20% strain.  This region was used to calculate the elastic modulus of the sample with a least squares 
regression for each sample.  The average elastic modulus was 324±141 kPa (n = 3).  However, as 
Figure 4.7 demonstrates, the entire curve is non-linear.  Therefore the elastic modulus is a highly 
variable value and should not be relied upon.  Due to the non-linearity of processed PAT, stress-
relaxation testing was performed.  Comparing processed PAT to SIS, PAT has a much lower 
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ultimate tensile stress and elastic modulus (87.4kPa vs. 22.6-61.3MPa and 324kPa vs. 8.28-
42.0MPa for the ultimate tensile stress and elastic moduli respectively). 
4.7 MSSR 
To explore the viscoelastic properties of processed PAT multiple 5-stage multi-stage stress-
relaxation experiments were conducted congruent to previous testing methods.  Reported results 
from similar experiments for SIS used a 15% loading per ramp and 100 seconds of relaxation over 
4 ramps in hydrated conditions [46].  For PAT, the total sample strain was reduced to 30%, to 
ensure the sample remained intact.  SIS and other soft tissues demonstrate strain hardening behavior 
[68]; this same behavior was observed for PAT after processing (Figure 4.8.a). As processed PAT 
was stretched in the first stage, the stress developed was significantly less than that developed in 
the fifth stage.  The relaxation behavior was different from that of chitosan and chitosan/gelatin 
porous scaffolds [25], polycaprolactone (PCL) scaffolds [26] and 50:50 poly-lactide-co-glycolide 
(PLGA) films [27].  Chitosan and chitosan-gelatin scaffolds showed no change in stress 
accumulation in successive stages.  The stress accumulation of PLGA films decreased in successive 
stages, leading to strain softening.  This difference could be attributed to the fact that 50:50 PLGA 
is an amorphous polymer whereas PCL is a semi-crystalline polymer.  
To better examine variation in profile between the stages, each stage was normalized by 
taking the ratio 
σ(t)
σmax
  where σ(t) is the stress at any given point in a stage with the beginning of 
each ramp to t = 0 , defined as the beginning of the stage and σmax  is the maximum stress 
developed in that stage which occurred at the end of the linear ramp.  This is called the reduced 
relaxation function G(t) and is described by Fung [39].  Figure 4.8.b shows the reduced relaxation 
function for each stage plotted simultaneously.  Both SIS and PAT experience an initial 
conditioning period.   As can be seem, the first stage profile is significantly different than the 2-5 
stages and significantly greater relaxation is observed during the first stage.  This is expected for 
 44 
 
tissues [39].  As can be seen, PAT shows a nearly 30% relaxation from the maximum stress in each 
stage.  This can be compared with chitosan scaffolds which show 90% relaxation at the end of each 
stage and with PCL which show 25% relaxation at the end of each stage. 
 
Figure 4.8:  Results of a characteristic MSSR experiment.  a) MSSR stress vs time curve.  b) The 
reduced, relative function vs time.  
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CHAPTER V 
 
 
CONCLUSIONS AND RECOMMENDATIONS:  PRESENT TO FUTURE 
 
5.1 CONCLUSIONS 
This study examined multiple non-toxic decellularization steps and a single toxic lipid removal step 
applicable to the native soft tissues.  Optimization of the decellularization methods was performed 
to meet the specific aims stated at the beginning of this thesis.  Moreover, the properties of the 
scaffold were determined, demonstrating the success of the developed process and comparing the 
developed scaffold to other soft tissue scaffolds; both those clinically available and those under 
investigation, with an emphasis on SIS as the most successful soft tissue scaffold currently 
available.  The findings of this study will be stated within the framework of the specific aims 
presented at the beginning of this work: 
1. Create a process that decellularizes PAT while maintaining its natural morphology. 
 The final process developed to decellularize PAT was shown in Figure 3.1.  
Freeze-thawing caused minimal damage to the ECM and could be used in 
conjunction with trypsinization to successfully decellularize PAT and was 
therefore optimized.  Additional steps were required to remove the lipid content of 
PAT and therefore additional sonication, lyophilization, and xylene immersion 
steps were introduced to remove the lipids from the unprocessed tissue.  
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 Cell seeding experiments demonstrated cellular attachment to the processed 
scaffold.  In addition, the experiments demonstrate cells spread throughout the 
matrix and are viable after 8-days. 
 The DNA content of processed PAT was examined and near total removal of DNA 
(99.92%) was demonstrated.  Moreover, by examining the absolute mass fraction 
of DNA in the processed scaffold on a dry basis, it was determined that processed 
PAT contains 0.218 DNA per mg dry scaffold.  Comparing this value to literature 
it was found to be negligible compared to the decellularization level that is likely 
to cause immune rejection. 
2.   Characterize PAT’s mechanical and physical properties. 
To characterize processed PAT, its morphology and microarchitecture were examined, 
multiple mechanical properties of the processed scaffold were determined and compared 
to clinically available scaffolds and to scaffolds under investigation in the literature.  
 As stated in the objective, a scaffold that maintained PAT’s native tissue 
morphology was sought.  Through visual microscopy of PAT throughout the 
decellularization steps, it was demonstrated that PAT’s native morphology 
remained intact.  In addition, the microarchitecture was examined using SEM.  
Through SEM micrographs, it was demonstrated that processed PAT is porous, 
that a network of vascular channels does remain intact within the tissue in an un-
collapsed state, and that the microscale morphology of PAT is mainly 
homogeneous without distinct regions that differ strongly from others in 
segregated areas.  This includes a lack of sidedness, a major heterogeneity seen in 
SIS. 
 Tensile testing conducted on processed PAT led to quantification of the average 
break stress and strain of the processed scaffold:  87.4±23.1 kPa and 53.9±13.3% 
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respectively.  Moreover, an approximate elastic modulus of 324±141 kPa was 
found between 14% and 20% strain. 
 5-stage MSSR testing was conducted and demonstrated that PAT has an initial 
conditioning period followed by consistent percent relaxation and strain hardening 
behavior (increasing stress per ramp).  In addition the relaxation behavior was 
compared to SIS, and found both to be strain hardening and found both to have the 
initial conditioning period.  The stress-relaxation properties were also compared to 
chitosan, chitosan-gelatin, polycaprolactone, and PLGA films.   
5.2 OUTLOOK 
The ultimate goal for any practical technology is commercialization.  PAT requires significant 
work before it will be ready for commercialization.  The first step along that path will be to utilize 
an in vivo animal model to explore the immunogenicity of the tissue.  Second, although many 
growth factors are known to be present in adipose tissues, the growth factors remaining in PAT 
after processing have yet to be determined.  Further experiments are necessary to quantify these 
properties.  In addition, to further quantify the viscoelastic properties of PAT, dynamic 
mechanical analysis, a form of cyclical testing will provide additional insight.   
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APPENDIX A 
 
Full list of optimization steps for Method 2 (continued onto next page): 
 
 
Method Freeze 
Solution
Freeze 
Temp 
(
o
C)
Number of 
Freeze-Thaw 
Cycles
Thaw 
Time
(min)
Trypsination time at 
37
o
C
(hr)
Approximate 
Sample Size
Testing 
Method
Additional Treatment Notes and Results
1 30% EtOH
2 50% EtOH
3 70% EtOH
4 1
5 2
6 3
7 4
8 1.0
9 50% EtOH -81 4 20 1.5 ~ 1x1x.2 cm
10 3.5
11 50% EtOH -81 4                                                       1.5 ~ 1x1x.2 cm Cell Seeding
histology of seeded tissue did not 
show nuclei
12 50% EtOH -81 4 20 3.0 R = 10 cm, .5 cm
freeze drying showed oily film, lipid 
content not removed (did not seed 
samples)
13 none no fat content reduction
14 100% EtOH no fat content reduction
15 50% EtOH no fat content reduction
16 70% EtOH no fat content reduction
17 Deionized H20 no fat content reduction
18a 75% EtOH ~ 2 mm
18b 90% EtOH ~ 0.5 mm
18c 75% EtOH ~ 2 mm
18d 90% EtOH ~ 0.5 mm
19a 6 1.5 • 24 hr in 100% EtOH
19b 6 1.5
19c 6 3 • 24 hr in 100% EtOH
19d 6 3
20a 7 1.5 • 24 hr in 100% EtOH
20b 7 1.5
20c 7 3 • 24 hr in 100% EtOH
20d 7 3
1.0
-81
Homogenization1.0201-81 ~ 1x1x.2 cm
Lipid Removal Optimization
fewer nuclei observed in 50% 
EtOH Solution
20 1.0
Histology
H&E Stain
Examination under scope indicated 
1.5 hr of trypsination sufficient to 
remove cell nuclei
Examination under scope indicated 
4 freeze-thaw cycles optimal
Histology
H&E Stain
50% EtOH
Histology
H&E Stain
~ 1x1x.2 cm
~ 1x1x.2 cm
-81 1 20
50% EtOH -81 60 ~ 1x1x.2 cm Freeze-drying
-81 4 20 1.5
All samples had oily lipid film on 
petri dish. Addititonal lipid content 
could be rubbed from samples.
Also soaked in ethanol before 
freezing to allow for diffusion. Still 
had oily substance upon freeze 
drying. 
Freeze-drying
Cellular Removal Optimization
5
3
 
1
2 
  
 
 
21 none N/A none N/A none ~ 1x1x.2 cm Freeze-drying 20 min in sonicator lipid still present
22
• 1 hr in trypsin in sonicator at 
room temp
• 30 minutes in trypsin at 37°C
lipid still present
23
• 1 hr sonication in water 
separate from trypsination lipid still present
24
• 1 hr sonication in water at 
46
°
C
lipid still present
25
• 1 hr sonication in water at 
50
°
C
lipid still present
26
• 1 hr sonication in SDS at 
Room Temp
lipid mostly removed
27 ~4x4x.1 cm lipid mostly removed
28 ~4x4x.2 cm lipid still present
29 ~4x4x.1 cm
lipid mostly removed, 27 appeared 
superior
30 ~4x4x.2 cm lipid still present
31 ~4x4x.1 cm
• 20 min sonication
• immersed in .21 M acetic 
acid for 30 minutes
lipid mostly removed
32 ~4x4x.1 cm
• 20 min sonication
• immersed in histological 
grade xylene for 20 seconds
lipid mostly removed
33 ~4x4x.1 cm
• 20 min sonication
• immersed in hystological 
grade xylene for 17 minutes
Lipid completely removed
34 ~4x4x.1 cm
• 20 min sonication
• immersed in hystological 
grade xylene for 20 
minutes
Lipid completely removed, no 
improvement over 33
50% EtOH -81 4 60 1.5 ~ 1x1x.2 cm Freeze-drying
Visual 
Examination
and
Mechanical 
Massaging
50% EtOH -81 4 60 1.5
Lipid Removal: Larger Samples
1.5604-8150% EtOH Freeze-drying
• frozen from 1°C
• 20 min sonication
• 20 min sonication
5
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